Home › Islet Cell Adenoma › Utah › Salt Lake City
Islet Cell Adenoma clinical trials in Salt Lake City, UT
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Salt Lake City
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- Farmington Health Center, Farmington · 15 mi away
Islet Cell Adenoma trials in other cities
- Los Angeles, CA5 studies
- Rochester, MN5 studies
- Washington, DC4 studies
- St. Louis, MO4 studies
- Portland, OR4 studies
- Phoenix, AZ4 studies
- Chicago, IL4 studies
- Philadelphia, PA3 studies
- Boston, MA3 studies
- Lexington, KY3 studies
- Jacksonville, FL3 studies
- Nashville, TN3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.